NCT02632435View on ClinicalTrials.gov

Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Breast CancerCancer
Interventions
DEVICE

PICC

Participants will be randomized to a PICC for vascular access during chemotherapy.

DEVICE

PORT

Participants will be randomized to a PORT for vascular access during chemotherapy

Trial Locations (1)

K1H 8L6

The Ottawa Hospital Cancer Centre, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER